Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply Intimation for Loss of Share Certificates 22nd May 2024 Cipla receives final approval for the generic version of Somatuline® Depot (lanreotide) Injection 22nd May 2024 Postal Ballot: Scrutiniser’s Report along with Voting Results 17th May 2024 Allotment of 50,768 equity shares under ESOS 2013-A Scheme and Cipla ESAR Scheme 2021 of the Comapny 17th May 2024 Acquisition of additional shares in Achira Labs Private Limited, associate company 15th May 2024 Sale of shares by the Promoter Group 15th May 2024 Resignation of Senior Management Personnel 14th May 2024 Outcome of Board Meeting Q4 FY 24 10th May 2024 Schedule of Analyst / Institutional Investor Meetings 09th May 2024 USFDA inspection at Company’s manufacturing facility in Kurkumbh, Maharashtra, India 08th May 2024 Pagination First page first Previous page ‹ Page 1 Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.